GCG and Impaired glucose tolerance: However, in animals where glucose dysmetabolism progresses from impaired glucose tolerance to diabetes with beta cell dysfunction, such chronic dopamine agonist treatment reduces hyperglycemia while actually improving (increasing) GSIS, including the beta cell response to glucagon like peptide-1 [46, 47].